Niranjan Kanesa-thasan - Jul 30, 2021 Form 4 Insider Report for Icosavax, Inc. (ICVX)

Role: Chief Medical Officer
Signature: /s/ Thomas Russo, Attorney-in-Fact
Stock symbol: ICVX
Transactions as of: Jul 30, 2021
Transactions value $: $722,490
Form type: 4
Date filed: 8/2/2021, 09:20 PM
Previous filing: Jul 28, 2021
Next filing: Feb 4, 2022

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	ICVX	Common Stock	Purchase	$100K	+6.67K		$15.00	6.67K	Aug 2, 2021	Direct
transaction	ICVX	Common Stock	Award	$623K	+41.5K	+32.64%	$15.00	169K	Jul 30, 2021	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	Represents restricted stock units ("RSUs") granted on July 30, 2021, 25% of the total number of RSUs granted vest on each of the first four anniversaries of July 28, 2021, the vesting commencement date, subject to the reporting person's continued service on the applicable vesting date. Vesting of the RSUs shall accelerate as provided in the reporting person's offer letter. Each RSU represents a contingent right to receive one share of common stock of the Issuer.

Content

Represents restricted stock units ("RSUs") granted on July 30, 2021, 25% of the total number of RSUs granted vest on each of the first four anniversaries of July 28, 2021, the vesting commencement date, subject to the reporting person's continued service on the applicable vesting date. Vesting of the RSUs shall accelerate as provided in the reporting person's offer letter. Each RSU represents a contingent right to receive one share of common stock of the Issuer.